Supplemental Newborn Screening by MS/MS-Based Second-Tier Testing
Newborn Screening in Minnesota
July 2008
First a few words about newborn screening in Minnesota. Four years ago a public/private partnership was formed between the Minnesota Department of Health and the Mayo Clinic. This partnership combines the strength of the Minnesota Department of Health and the administration of a comprehensive newborn screening program of approximately 75,000 babies born each year and Mayo Clinic’s analytical and interpretive expertise in the performance of complex assays and technologies such as tandem mass spectrometry.
Newborn Screening in Minnesota |
Jump to section:
- Introduction
- What is Newborn Screening?
- Evolution of Newborn Screening
- ACMG* Uniform Panel
- MS/MS Impact on Newborn Screening
- Newborn Screening Performance in the USA (MS/MS)
- Costs of False-Positive NBS Results
- Newborn Screening in Minnesota
- MN Newborn Screening Program
- Costs of False-Positive NBS Results
- What is Second-Tier Testing?
- Second-Tier Testing is Performed for the Following "Problem" Analytes
- Why Second-Tier Testing?
- Costs of False-Positive NBS Results
- Impact of Second-Tier Testing on Performance of Newborn Screening by MS/MS at Mayo Clinic
- Questions?
External
link
PDF
document
Excel
document
Word
document